Activation of macrophage cytostatic effector mechanisms during acute graft-versus-host disease: release of intracellular iron and nitric oxide–mediated.

Slides:



Advertisements
Similar presentations
Induction of Graft-versus-Leukemia (GVL) Effect without Graft-versus-Host Disease (GVHD) by Pretransplant Donor Treatment with Immunomodulators  Shoshana.
Advertisements

Recombinant CD95-Fc (APG101) prevents graft-versus-host disease in mice without disabling antitumor cytotoxicity and T-cell functions by Natalie Hartmann,
Probiotic effects on experimental graft-versus-host disease: let them eat yogurt by Armin Gerbitz, Michael Schultz, Andrea Wilke, Hans-Jörg Linde, Jürgen.
Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease by Tangsheng Yi, Ying Chen, Lin Wang,
High-Risk Acute Lymphoblastic Leukemia Cells with bcr-abl and Ink4a/Arf Mutations Retain Susceptibility to Alloreactive T Cells  Faith M. Young, Andrew.
Blood Dendritic Cells Suppress NK Cell Function and Increase the Risk of Leukemia Relapse after Hematopoietic Cell Transplantation  Antonio Perez-Martinez,
by Masako Moriuchi, Hiroyuki Moriuchi, and Anthony S. Fauci
by JoAnn Castelli, Elaine K
Extracellular ubiquitin inhibits the TNF-α response to endotoxin in peripheral blood mononuclear cells and regulates endotoxin hyporesponsiveness in critical.
Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human.
Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment by Francis Mussai, Carmela De Santo, Issa Abu-Dayyeh, Sarah Booth,
Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing by Michael Dechant, Gestur Vidarsson, Bernhard Stockmeyer, Roland.
by Jordi Xaus, Mònica Comalada, Annabel F
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Megakaryocyte Growth and Development Factor-Induced Proliferation and Differentiation Are Regulated by the Mitogen-Activated Protein Kinase Pathway in.
CCR2 is required for CD8-induced graft-versus-host disease
by Kirsteen H. Maclean, John L. Cleveland, and John B. Porter
by Yoshinobu Maeda, Pavan Reddy, Kathleen P
Ping Zhang, Jieying Wu, Divino Deoliveira, Nelson J. Chao, Benny J
by Silke Huber, Reinhard Hoffmann, Femke Muskens, and David Voehringer
Impaired negative regulation of homeostatically proliferating T cells
by Norman Nausch, Ioanna E
Metalloproteinases Are Involved in Lipopolysaccharide– and Tumor Necrosis Factor-–Mediated Regulation of CXCR1 and CXCR2 Chemokine Receptor Expression.
Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes
Ikaros-Notch axis in host hematopoietic cells regulates experimental graft-versus-host disease by Tomomi Toubai, Yaping Sun, Isao Tawara, Ann Friedman,
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
Ex Vivo Rapamycin Generates Th1/Tc1 or Th2/Tc2 Effector T Cells With Enhanced In Vivo Function and Differential Sensitivity to Post-transplant Rapamycin.
Anti–factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome by Mihály Józsi, Stefanie Strobel, Hans-Martin.
LBH589 Enhances T Cell Activation In Vivo and Accelerates Graft-versus-Host Disease in Mice  Dapeng Wang, Cristina Iclozan, Chen Liu, Changqing Xia, Claudio.
Circulating forms of intercellular adhesion molecule (ICAM)-1 in mice lacking membranous ICAM-1 by Natasja K. van den Engel, Edmund Heidenthal, Antje Vinke,
Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator by Yan Jiao, John Wilkinson, Xiumin Di, Wei Wang,
IL-12hi Rapamycin-Conditioned Dendritic Cells Mediate IFN-γ–Dependent Apoptosis of Alloreactive CD4+ T Cells In Vitro and Reduce Lethal Graft-Versus-Host.
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.
The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease by Shan He, Fang.
Rare cells predict GVHD
Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15 by Maria Wysocka, Bernice M. Benoit, Sarah.
Hematopoietic stimulation by a dipeptidyl peptidase inhibitor reveals a novel regulatory mechanism and therapeutic treatment for blood cell deficiencies.
by Sheng F. Cai, Xuefang Cao, Anjum Hassan, Todd A
IFNγ differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract by Angela C. Burman, Tatjana Banovic,
Ifosfamide impairs the allostimulatory capacity of human dendritic cells by intracellular glutathione depletion by Maria C. Kuppner, Anabel Scharner, Valeria.
by Bindu Varghese, Adam Widman, James Do, Behnaz Taidi, Debra K
Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties by Frederick D. Goldman, Andrew L. Gilman,
by Oleg I. Krijanovski, Geoffrey R. Hill, Kenneth R
Induction of Graft-versus-Leukemia (GVL) Effect without Graft-versus-Host Disease (GVHD) by Pretransplant Donor Treatment with Immunomodulators  Shoshana.
Graft-Versus-Leukemia Effect and Graft-Versus-Host Disease Can Be Differentiated by Cytotoxic Mechanisms in a Murine Model of Allogeneic Bone Marrow Transplantation.
Blood Dendritic Cells Suppress NK Cell Function and Increase the Risk of Leukemia Relapse after Hematopoietic Cell Transplantation  Antonio Perez-Martinez,
Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6 by Michelle A. Kilmon, Nikki J. Wagner, Alaina.
by Ulrike Schleicher, Andrea Hesse, and Christian Bogdan
Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential by Amy S. Rawls, Alyssa D. Gregory,
Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease by Tangsheng Yi, Dongchang Zhao, Chia-Lei.
Inhibition of Cathepsin S Reduces Allogeneic T Cell Priming but Not Graft-versus-Host Disease Against Minor Histocompatibility Antigens  Hisaki Fujii,
Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice  Yongxia Wu, David Bastian, Steven Schutt, Hung Nguyen,
T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease  Cristina Iclozan, Yu Yu, Chen Liu, Yaming Liang, Tangsheng.
Volume 18, Issue 3, Pages (March 2003)
Effector Cells Derived from Host CD8 Memory T Cells Mediate Rapid Resistance against Minor Histocompatibility Antigen-Mismatched Allogeneic Marrow Grafts.
by Kalpana Parvathaneni, and David W. Scott
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response 
VEGF-A concentration is increased in vivo in response to DC101 and in vitro in response to FG VEGF-A concentration is increased in vivo in response.
Raimon Duran-Struuck, Isao Tawara, Kathi Lowler, Shawn G
Serial vaccination with 32Dp210-derived whole cell vaccines in non-tumor-bearing mice stimulates robust antileukemic cytolytic activity. Serial vaccination.
Regulation by Interleukin-10 and Interleukin-4 of Cyclooxygenase-2 Expression in Human Neutrophils by Hiroaki Niiro, Takeshi Otsuka, Kenji Izuhara, Kunihiro.
Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect  Shawn G Clouthier,
Figure 3 Fingolimod inhibits TNF-α secretion by human monocytes Peripheral blood mononuclear cells from healthy donors were briefly exposed to increasing.
Prospective Monitoring of Tumor Necrosis Factor α and Interferon γ to Predict the Onset of Acute and Chronic Graft-versus-Host Disease after Allogeneic.
Volume 60, Issue 6, Pages (December 2001)
Roles of CD28, CTLA4, and Inducible Costimulator in Acute Graft-versus-Host Disease in Mice  Jun Li, Kenrick Semple, Woong-Kyung Suh, Chen Liu, Fangping.
IL-17A mediates cutaneous GVHD
Inhibitory effects of nobiletin and resveratrol on LPS/IFN-γ-induced NO generation in RAW cells. Inhibitory effects of nobiletin and resveratrol.
Proliferation of TA3-Ha and TA3-St cells in vitro and in vivo.
Presentation transcript:

Activation of macrophage cytostatic effector mechanisms during acute graft-versus-host disease: release of intracellular iron and nitric oxide–mediated cytostasis by Frederick P. Nestel, Robert N. Greene, Krikor Kichian, Premysl Ponka, and Wayne S. Lapp Blood Volume 96(5):1836-1843 September 1, 2000 ©2000 by American Society of Hematology

LPS dose response for Mφ-mediated release of intracellular iron from target cells during acute GVH.Target cell release of 59Fe (○) and 51Cr (▵) mediated by Mφ from normal B6AF1 mice and release of 59Fe (●) and 51Cr (▴) mediated by Mφ from acute GVHD B6AF1 m... LPS dose response for Mφ-mediated release of intracellular iron from target cells during acute GVH.Target cell release of 59Fe (○) and 51Cr (▵) mediated by Mφ from normal B6AF1 mice and release of 59Fe (●) and 51Cr (▴) mediated by Mφ from acute GVHD B6AF1 mice transplanted 14 days previously with 60 × 106 B6 cells. Mφ-mediated radioisotope release was determined using 59Fe,51Cr dual-labeled MDW4 cells in an 18-hour assay as described in “Materials and methods.” Each value represents the mean ± SD of 4 replicates of pooled Mφ effector cells. Similar results were obtained in 2 separate experiments. Frederick P. Nestel et al. Blood 2000;96:1836-1843 ©2000 by American Society of Hematology

NMMA inhibits NO production and cytostatic activity mediated by acute GVHD-primed, LPS-triggered Mφ.Acute GVHD Mφ (▪) from B6AF1 animals transplanted 14 days previously with 60 × 106 B6 cells were activated with 2.5 ng/mL LPS, and normal Mφ (■) from B6AF1an... NMMA inhibits NO production and cytostatic activity mediated by acute GVHD-primed, LPS-triggered Mφ.Acute GVHD Mφ (▪) from B6AF1 animals transplanted 14 days previously with 60 × 106 B6 cells were activated with 2.5 ng/mL LPS, and normal Mφ (■) from B6AF1animals were activated with 2.5 ng/mL LPS and IFN-γ. (A) The concentration of NO in 48-hour culture supernatants was determined as described in “Materials and methods.” Mφ were cultured in phenol red–free RPMI 1640 containing 1.0 mmol/L L-arginine plus 10% FCS with or without NMMA as indicated. Results represent the mean ± SD of triplicates. Similar results were obtained in 2 separate experiments. (B) Mφ-mediated cytostasis of MDW4 cells was determined as described in “Materials and methods.” Mφ and targets were cultured for 48 hours in RPMI 1640 plus 10% FCS containing 1.0 mmol/L L-arginine either with or without NMMA as indicated. Results represent the mean ± SEM of 3 experiments. Frederick P. Nestel et al. Blood 2000;96:1836-1843 ©2000 by American Society of Hematology